Oreste Buonomo to Humans
This is a "connection" page, showing publications Oreste Buonomo has written about Humans.
Connection Strength
0.127
-
Unusual Presentation of a Post-procedural Breast Hematoma: A Case Report. In Vivo. 2021 Sep-Oct; 35(5):2957-2961.
Score: 0.008
-
Impact of COVID-19 Pandemic on Surgical Breast Cancer Patients Undergoing Neoadjuvant Therapy: A Multicentric Study. Anticancer Res. 2021 Sep; 41(9):4535-4542.
Score: 0.008
-
Extremely Advanced Breast Cancer Presentation: Possible Effect of Coronavirus Pandemic Anxiety. In Vivo. 2021 Jul-Aug; 35(4):2331-2335.
Score: 0.008
-
Advanced Stages and Increased Need for Adjuvant Treatments in Breast Cancer Patients: The Effect of the One-year COVID-19 Pandemic. Anticancer Res. 2021 May; 41(5):2689-2696.
Score: 0.008
-
Lymphocytes, Interleukin 6 and D-dimer Cannot Predict Clinical Outcome in Coronavirus Cancer Patients: LyNC1.20 Study. Anticancer Res. 2021 Jan; 41(1):307-316.
Score: 0.007
-
COVID-19 Unintended Effects on Breast Cancer in Italy After the Great Lockdown. Front Public Health. 2020; 8:601748.
Score: 0.007
-
Delay in Breast Cancer Treatments During the First COVID-19 Lockdown. A Multicentric Analysis of 432 Patients. Anticancer Res. 2020 Dec; 40(12):7119-7125.
Score: 0.007
-
Effect of Lockdown in Surgical Emergency Accesses: Experience of a COVID-19 Hospital. In Vivo. 2020 Sep-Oct; 34(5):3033-3038.
Score: 0.007
-
Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario. In Vivo. 2020 Sep-Oct; 34(5):3047-3053.
Score: 0.007
-
Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency. Breast Cancer. 2021 Jan; 28(1):137-144.
Score: 0.007
-
Breast Cancer and COVID-19: The Effect of Fear on Patients' Decision-making Process. In Vivo. 2020 Jun; 34(3 Suppl):1651-1659.
Score: 0.007
-
Tor Vergata University-Hospital in the Beginning of COVID-19-Era: Experience and Recommendation for Breast Cancer Patients. In Vivo. 2020 Jun; 34(3 Suppl):1661-1665.
Score: 0.007
-
The Effect of Coronavirus (COVID-19) on Breast Cancer Teamwork: A Multicentric Survey. In Vivo. 2020 Jun; 34(3 Suppl):1685-1694.
Score: 0.007
-
Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer. Anticancer Res. 2018 Dec; 38(12):6639-6652.
Score: 0.006
-
Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features. Anticancer Res. 2018 04; 38(4):2109-2117.
Score: 0.006
-
New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes. PLoS One. 2017; 12(9):e0184680.
Score: 0.006
-
PET Probe-Guided Surgery in Patients with Breast Cancer: Proposal for a Methodological Approach. In Vivo. 2017 01 02; 31(1):101-110.
Score: 0.006
-
Splenoportal-mesenteric axis thrombosis and splenic artery occlusion as initial presentations of COVID-19 disease. Eur Rev Med Pharmacol Sci. 2021 Feb; 25(3):1680-1683.
Score: 0.002
-
Editorial - Breast cancer: awake surgery as strategy during second COVID-19 lockdown? Eur Rev Med Pharmacol Sci. 2020 12; 24(24):13101-13102.
Score: 0.002
-
Chest Computed Tomography Scoring in Patients With Novel Coronavirus-infected Pneumonia: Correlation With Clinical and Laboratory Features and Disease Outcome. In Vivo. 2020 Nov-Dec; 34(6):3735-3746.
Score: 0.002
-
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential. Tumori. 2020 Apr; 106(2):115-125.
Score: 0.002